FSCN1 and posterior cortical atrophy: In PCa patients, FSCN1 expression was experimentally investigated by immunohistochemistry in benign, localized and hormone-refractory PCa and found to be highly expressed in hormone refractory PCa and localized PCa, reporting that epithelial expression of FSCN1 is not statistically significant associated with Gleason score, pathologic stage or surgical margins [39].